Ravinder Singh, Ph.D., Discusses the Need for Advanced Diagnostic Technology to Counter Cancer in Punjab

By Kelley Luedke • July 20, 2018

Share this:

Ravinder Singh, Ph.D., a consultant in the Division of Clinical Biochemistry and Immunology at Mayo Clinic in Rochester, Minnesota, was recently featured in Hindustan Times after he spoke at a seminar in India sponsored by his alma mater, Guru Nanak Dev University. Expressing concern over the growing danger of deadly diseases, including cancer, in Punjab, Dr. Singh stated that the state needs advanced diagnostic technology to counter cancer and other diseases.

According to Dr. Singh, “Cancer is a big threat to the health of Punjabis due to various factors. All know it is curable only if it is diagnosed at an early stage. However, the state does not have an advanced technology to diagnose it at an early stage. In such a situation, it is not easy to treat the disease. There are good laboratories here, but these are very few."

Dwelling on liquid chromatography–mass spectrometry (LC-MS) technology, Dr. Singh said this is a new technology to diagnose deadly diseases. He said, “Besides cancer, blood pressure and diabetes afflicting Indians to a great extent also need better diagnostic technology.”

Dr. Singh said he has been in contact with the All India Institute of Medical Sciences for introduction of this technology and will make efforts to help in introducing better diagnostic technology in Punjab as well. “We need to sensitize the Punjabis about their health, which is facing serious challenges,” he added.

Kelley Luedke

Kelley Luedke is a Marketing Channel Manager at Mayo Clinic Laboratories. She is the principle editor and writer of Insights and leads social media and direct marketing strategy. Kelley has worked at Mayo Clinic since 2013. Outside of work, you can find Kelley running, traveling, playing with her kitty, and exploring new foods.